In the unpredictable theater of global finance, few figures command attention quite like Donald J. Trump. His pronouncements, often delivered with the subtlety of a sledgehammer, consistently send ripples, if not tidal waves, through the stock markets. The closing weeks of 2025 have proven no exception, offering a fresh batch of market-moving maneuvers that leave analysts scratching their heads and investors reaching for their antacids. From “historic” drug price cuts that somehow boost pharma stocks to a s ...